Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI · MIL
Bulios Fair Price
37.59 €
27.9% downside
Current Price
52.1 €
According to Bulios Fair Price, REC.MI is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Recordati Industria Chimica e Farmaceutica S.p.A. is an Italian pharmaceutical company specializing in the development, manufacture, and distribution of drugs. The company focuses on the treatment of rare and chronic diseases in both the pharmaceutical and biotechnology sectors. Recordati operates globally, and its portfolio includes products in cardiovascular, neurological, endocrinological, and urological conditions. The company is also involved in research and development of new drugs and therapies to meet patient needs.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Robert Koremans
Employees
4,693
Headquarters
Milan
Upcoming events
Earnings
Upcoming earnings report